Your session is about to expire
← Back to Search
Positive Psychology Intervention for Caregivers of Blood Cancer Patients (PATH-C Trial)
N/A
Recruiting
Led By Hermioni L Amonoo, MD, MPP
Research Sponsored by Brigham and Women's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1 year
Awards & highlights
PATH-C Trial Summary
This trial is testing whether an intervention focused on positive emotions can reduce caregiver burden and improve health outcomes for caregivers of stem cell transplant recipients.
Who is the study for?
This trial is for adult caregivers (18+ years) of patients undergoing allogeneic stem cell transplant at DCFI. They must speak English, be able to complete questionnaires with minimal help, and have close contact with the patient at least twice a week. Caregivers with cognitive deficits that affect their ability to consent or participate are excluded.Check my eligibility
What is being tested?
The study tests a Positive Psychology Intervention aimed at reducing caregiver burden by enhancing positive emotions among those caring for blood cancer patients receiving stem cell transplants. It seeks to improve caregivers' quality of life and health outcomes.See study design
What are the potential side effects?
Since this intervention focuses on psychological support rather than medication, traditional physical side effects are not expected. However, participants may experience emotional responses as they engage in the program.
PATH-C Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Refinement of a positive psychology intervention in caregivers based on qualitative feedback of five participants
Secondary outcome measures
Feasibility and acceptability of the PATH intervention assessed by participant ratings of ease and utility on a 10 point likert scale after each weekly intervention session
PATH-C Trial Design
1Treatment groups
Experimental Treatment
Group I: PATH InterventionExperimental Treatment1 Intervention
Participants in the PATH Intervention arm will receive psychosocial support phone calls during week 1 through 9 following enrollment.
After consent procedures, participants will begin an 9-week positive-psychology program involving weekly calls with an interventionist and exercises (i.e. writing a letter of gratitude, identifying personal strengths, planning meaningful and enjoyable activities).
Self-assessment questionnaires to measure positive affect, health behaviors, and overall function before and after completing the Positive Psychology Intervention.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Positive Psychology Intervention
2022
N/A
~90
Find a Location
Who is running the clinical trial?
Brigham and Women's HospitalLead Sponsor
1,609 Previous Clinical Trials
11,470,302 Total Patients Enrolled
Dana-Farber Cancer InstituteLead Sponsor
1,079 Previous Clinical Trials
340,923 Total Patients Enrolled
Hermioni L Amonoo, MD, MPPPrincipal InvestigatorDana-Farber Cancer Institute
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: PATH Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many participants are being recruited for this experiment?
"Affirmative, information on clinicaltrials.gov reveals that this medical trial is currently looking to enroll individuals. This research was initially posted on March 1st 2022 and has been modified as recently as July 3rd 2022. To date, 25 patients have already signed up at a single location."
Answered by AI
Is enrollment in this trial still available?
"Per information on clinicaltrials.gov, this investigation is still recruiting trial participants. It was first publicized on March 1st 2022 and had its last update published seven days later."
Answered by AI
Share this study with friends
Copy Link
Messenger